MusclePharm Corporation (MSLPQ)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0945 - Volume
15,000 - Avg. Volume
0 - Market Cap (intraday)
34 - Beta (5Y Monthly) 33.24
- PE Ratio (TTM)
-- - EPS (TTM)
-0.5800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada. On December 15, 2022, MusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Nevada.
www.musclepharm.com21
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: MSLPQ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MSLPQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MSLPQ
Valuation Measures
Market Cap
41.22k
Enterprise Value
22.15M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.00
Price/Book (mrq)
--
Enterprise Value/Revenue
0.44
Enterprise Value/EBITDA
-1.37
Financial Highlights
Profitability and Income Statement
Profit Margin
-38.50%
Return on Assets (ttm)
-66.50%
Return on Equity (ttm)
--
Revenue (ttm)
50.02M
Net Income Avi to Common (ttm)
-19.26M
Diluted EPS (ttm)
-0.5800
Balance Sheet and Cash Flow
Total Cash (mrq)
534k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3.44M
Company Insights: MSLPQ
MSLPQ does not have Company Insights